Objectives: Although the prostaglandin-mediated mucosal protection wit
hin the gastric compartment has been well established, its potential r
ole in the maintenance of integrity of the esophageal mucosa in humans
has not been explored due to the lack of appropriate methodology. Met
hods: We have recently developed an esophageal perfusion catheter, equ
ipped with two balloons, compartmentalizing a 7.5-cm segment of the es
ophageal lumen. Using this catheter, we studied the impact of the lumi
nal perfusion with saline, HCl (0.01 M, pH 2.1), and HCl/pepsin soluti
ons (0.5 mg/ml) on esophageal luminal release of PGE2 in 21 asymptomat
ic, presumably healthy volunteers (12 M, 9F; mean age 40 yr). The cont
ent of PGE2 in its methyl oximated form was measured by RIA (Amersham,
IL), using a novel iodinated label. Results are expressed as mean +/-
SEM. Student's t test was used for statistical analysis. Results: Per
fusion of the esophageal lumen resulted in continuous release of PGE2
into the perfusate at the rate of 1880 +/- 393 pg/min during the first
8-min perfusion period. During continuation of perfusion with saline,
the luminal release of PGE2 was maintained at the rate of 1820 +/- 64
0 pg/min during the second 8-min perfusion period. This rate declined
(although in nonsignificant fashion; p < 0.2) during the third perfusi
on period, reaching a plateau of 1220 +/- 473 pg/min and maintained du
ring the last (period IV) perfusion period with saline. Introduction o
f acid during the perfusion period II in the second group of investiga
ted subjects resulted in a rapid and statistically significant decline
of the luminal release of PGE2 to the value of 1020 +/- 167 ng/min (p
< 0.01). Continuation of esophageal perfusion with acid during the ne
xt 8-min perfusion period further diminished the luminal release of PG
E2 to the value of 520 +/- 73; p < 0.001. The significant decline in t
he rate of luminal PGE2 release was still maintained despite the repla
cement of acid with saline during the ending 8-min perfusion (period I
V; 560 +/- 80 ng/min; p < 0.001). Esophageal perfusion with HCl/pepsin
solution, in group III subjects, potentiated luminal release of PGE2,
reaching the value of 1553 +/- 340 pg/min, which is 3 times higher th
an the value of PGE2 observed during corresponding perfusion with HCl
(period III; p < 0.03). This significant impact of HCl/pepsin solution
was still maintained despite the substitution of HCl/pepsin with NaCl
during the last perfusion period, and was still significantly higher
(1260 +/- 220 pg/min; p < 0.02) than the corresponding value during th
e ending perfusion with NaCl after HCl (group II). This study for the
first time demonstrates that luminal release of PGE2 in humans remains
under a significant impact of luminal chemical factors such as acid a
nd pepsin. Conclusion: The modulatory effect of acid and pepsin on eso
phageal mucosal prostaglandin release may play a role in the developme
nt of reflux-related mucosal pathology.